Abstract
Multiple forms of cytochrome P450 (P450) in brain tissue have been demonstrated to be expressible in brain tissue using polymerase chain reaction (PCR) techniques, Northern blotting, hydroxylation activity assessment and cloning approaches. The antidepressant drug imipramine is metabolized by brain microsomes to multiple products by pathways inhibitable by quinidine, 7,8-benzoflavone, and ketoconazole, well-known inhibitors of P450-catalyzed reactions. Moreover, PCR studies revealed that a number of P450s are expressible in brain tissue and in glioma C6 cells. Quantitative PCR studies further demonstrated the response of many of these forms to induction in agreement with hydroxylation activity results.
Original language | English (US) |
---|---|
Pages (from-to) | 639-643 |
Number of pages | 5 |
Journal | Toxicology Letters |
Volume | 82-83 |
Issue number | C |
DOIs | |
State | Published - Dec 1995 |
Keywords
- Brain P450 isozyme expression
- Brain cytochrome P450
- Brain drug metabolizing system
ASJC Scopus subject areas
- Toxicology